Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 70/100

Failure Rate

50.0%

5 terminated/withdrawn out of 10 trials

Success Rate

16.7%

-69.8% vs industry average

Late-Stage Pipeline

30%

3 trials in Phase 3/4

Results Transparency

500%

5 of 1 completed trials have results

Key Signals

3 recruiting5 with results

Enrollment Performance

Analytics

Phase 4
3(42.9%)
N/A
3(42.9%)
Phase 1
1(14.3%)
7Total
Phase 4(3)
N/A(3)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)